Related Experiment Video

Updated: Jun 25, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Type 2 diabetes and coronary heart disease: focus on myocardial infarction

Rodrigo M Lago1, Richard W Nesto

  • 1Lahey Clinic Medical Center, 41 Mall Road, Burlington, MA 01805, USA.

Current Diabetes Reports
|February 5, 2009
PubMed

Insights

Individuals with type 2 diabetes face higher risks of myocardial infarction and poorer outcomes. Managing diabetes and heart health aggressively is crucial for better survival rates after a heart attack.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathophysiology

Background:

  • Type 2 diabetes (T2D) is linked to increased myocardial infarction (MI) incidence and severity.
  • Diabetic patients exhibit accentuated atherosclerosis and a prothrombotic state, worsening MI outcomes.
  • Metabolic dysfunction in T2D impairs compensatory mechanisms, leading to larger infarcts and reduced left ventricular function.

Purpose of the Study:

  • To elucidate the impact of type 2 diabetes on myocardial infarction pathophysiology and outcomes.
  • To highlight the challenges in treating MI in diabetic patients.
  • To emphasize the importance of aggressive management strategies.

Main Methods:

  • Review of existing literature on type 2 diabetes and myocardial infarction.
  • Analysis of pathophysiological differences between diabetic and non-diabetic individuals experiencing MI.
  • Evaluation of treatment challenges and outcomes in diabetic MI patients.

Main Results:

  • The atherosclerotic process is accelerated in T2D, though fundamentally similar.
  • A prothrombotic state in diabetes significantly increases MI incidence and mortality.
  • Reperfusion therapies are less effective due to diffuse coronary disease and altered vessel structure in T2D patients.

Conclusions:

  • Type 2 diabetes confers a worse prognosis following myocardial infarction due to accelerated atherosclerosis, a prothrombotic state, and impaired compensatory mechanisms.
  • Effective management requires aggressive medical therapy and meticulous glucose control during acute and follow-up phases.
  • Optimizing metabolic control is key to improving outcomes and reducing morbidity/mortality in diabetic patients with MI.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.